STEPHEN CHESTER SUFFIN, M.D.
Medical Practice at Fallbrook Ave, Canoga Park, CA
License number
California G025413
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
2
8401 Fallbrook Ave, Canoga Park, CA 91304
13151 Chandler Blvd, Van Nuys, CA 91401
13151 Chandler Blvd, Van Nuys, CA 91401
Phone
(818) 737-6266
(818) 737-6076 (Fax)
(818) 997-7660
(818) 737-6076 (Fax)
(818) 997-7660
Personal information
See more information about STEPHEN CHESTER SUFFIN at radaris.comName
Address
Phone
149 Castle Ct, Lafayette, CA 94549
13151 Chandler Blvd, Van Nuys, CA 91401
161 Fremont Rd, Arnold, CA 95223
400 Riviera Pl, San Rafael, CA 94901
161 Fremont Rd, Lafayette, CA 94549
Professional information
Eeg Prediction Method For Medication Response
US Patent:
8239013, Aug 7, 2012
Filed:
Feb 10, 2005
Appl. No.:
11/054762
Inventors:
Stephen C. Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Malibu CA, US
W. Hamlin Emory - Malibu CA, US
Assignee:
CNS Response, Inc. - Aliso Viejo CA
International Classification:
A61B 5/04
US Classification:
600544, 600300, 600545
Abstract:
The present invention includes a system and method for computerized analysis of a patient's electroencephalogram (EEG) recorded by electrodes placed on the scalp, for the purpose of predicting patient response to medications and therapeutic agents commonly used in psychiatric practice. The prediction of the responses to medications (adverse, no effect, favorable outcome) is an important problem in the clinical practice of psychiatry. A growing number of therapeutic agents are available to the clinician but these agents generate variable responses when prescribed based solely on the patient's history and current symptoms. The present invention is used by physicians to improve patient outcome by selecting agents most likely to be effective for a given patient, using a standardized analysis of the digitized EEG and comparison of individual patient EEC data to a particular database of similar patients whose clinical outcome to pharmacotherapy is known.
Compositions And Methods For Treatment Of Nervous System Disorders
US Patent:
2005009, May 5, 2005
Filed:
Oct 30, 2003
Appl. No.:
10/697497
Inventors:
Stephen Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Malibu CA, US
Leonard Brandt - San Juan Capistrano CA, US
W. Hamlin Emory - Malibu CA, US
Leonard Brandt - San Juan Capistrano CA, US
Assignee:
CNS Response - Santa Anna CA
International Classification:
A61K031/55, A61K031/137
US Classification:
514217000, 514649000
Abstract:
The present invention contemplates compositions and methods to treat patients having a nervous system disorder with a formulation comprising an anticonvulsant and a neuroactive modulator. Also described is a method to predict the probability of a significant recovery when a treating an individual patient having a nervous system disorder with a formulation comprising an anticonvulsant and a neuroactive modulator. Specifically, methods for predicting patient prognosis include, but are not limited to, quantitative electroencephalography, psychometric test batteries, biological indicators, brain metabolic indicators, genotype profiles, neuroimaging, objective test measurements and multi-modalities. The present invention also discloses a device providing an organized dispensation of the above formulations such that the patient or medical personnel may easily and accurately decrease the daily dosage of a third drug and increase the daily dosage of a formulation comprising an anticonvulsant and a neuroactive modulator.
Eeg Prediction Method For Medication Response
US Patent:
2003014, Jul 31, 2003
Filed:
Aug 15, 2001
Appl. No.:
09/930632
Inventors:
Stephen Suffin - Sherman Oaks CA, US
W. Emory - Malibu CA, US
W. Emory - Malibu CA, US
International Classification:
G06F017/60
US Classification:
705/002000
Abstract:
The present invention includes a system and method for computerized analysis of a patient's electroencephalogram (EEG) recorded by electrodes placed on the scalp, for the purpose of predicting patient response to medications and therapeutic agents commonly used in psychiatric practice. The prediction of the responses to medications (adverse, no effect, favorable outcome) is an important problem in the clinical practice of psychiatry. A growing number of therapeutic agents are available to the clinician but these agents generate variable responses when prescribed based solely on the patient's history and current symptoms. The present invention is used by physicians to improve patient outcome by selecting agents most likely to be effective for a given patient, using a standardized analysis of the digitized EEG and comparison of individual patient EEC data to a particular database of similar patients whose clinical outcome to pharmacotherapy is known.
Electroencephalography Based Systems And Methods For Selecting Therapies And Predicting Outcomes
US Patent:
7177675, Feb 13, 2007
Filed:
Jul 11, 2002
Appl. No.:
10/193735
Inventors:
Stephen C. Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - Laguna Hills CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - Laguna Hills CA, US
Assignee:
CNS Response, Inc - Long Beach CA
International Classification:
A61B 5/02
US Classification:
600544, 600300
Abstract:
A method and system for utilizing neurophysiologic information obtained by techniques such as quantitative electroencephalography (QEEG), electrode recordings, MRI in appropriately matching patients with therapeutic entities is disclosed. The present invention enables utilization of neurophysiologic information, notwithstanding its weak correlation with extant diagnostic schemes for mental disorders, for safer and expeditious treatment for mental disorders, discovering new applications for therapeutic entities, improved testing of candidate therapeutic entities, inferring the presence or absence of a desirable response to a treatment, and deducing the mode of action of one or more therapeutic entities. In particular, methods for effectively comparing neurophysiologic information relative to a reference set are disclosed along with database-based tools for deducing therapeutic entity actions on particular patients such that these tools are readily accessible to remote users.
Compositions And Methods For Treatment Of Nervous System Disorders
US Patent:
2005011, Jun 2, 2005
Filed:
Oct 22, 2004
Appl. No.:
10/972188
Inventors:
Stephen Suffin - Sherman Oaks CA, US
W. Emory - Malibu CA, US
Leonard Brandt - San Juan Capistrano CA, US
W. Emory - Malibu CA, US
Leonard Brandt - San Juan Capistrano CA, US
International Classification:
A61K038/05, A61K031/5377, A61K031/522, A61K031/445, A61K031/137, A61K031/138, A61K031/403, A61K035/78
US Classification:
424752000, 514018000, 514263310, 514411000, 514317000, 514649000, 514651000, 514618000, 514235500
Abstract:
The present invention contemplates compositions and methods to treat patients having a nervous system disorder with a formulation comprising an anticonvulsant and a neuroactive modulator. Also described is a method to predict the probability of a significant recovery when a treating an individual patient having a nervous system disorder with a formulation comprising an anticonvulsant and a neuroactive modulator. Specifically, methods for predicting patient prognosis include, but are not limited to, quantitative electroencephalography, psychometric test batteries, biological indicators, brain metabolic indicators, genotype profiles, neuroimaging, objective test measurements and multi-modalities. The present invention also discloses a device providing an organized dispensation of the above formulations such that the patient or medical personnel may easily and accurately decrease the daily dosage of a third drug and increase the daily dosage of a formulation comprising an anticonvulsant and a neuroactive modulator.
Electroencephalography Based Systems And Methods For Selecting Therapies And Predicting Outcomes
US Patent:
7489964, Feb 10, 2009
Filed:
Nov 29, 2006
Appl. No.:
11/605585
Inventors:
Stephen C. Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - Laguna Hills CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - Laguna Hills CA, US
Assignee:
CNS Response, Inc. - Costa Mesa CA
International Classification:
A61B 5/04, A61K 49/00
US Classification:
600544, 600545, 424 92
Abstract:
A method and system for utilizing neurophysiologic information obtained by techniques such as quantitative electroencephalography (QEEG), electrode recordings, MRI in appropriately matching patients with therapeutic entities is disclosed. The present invention enables utilization of neurophysiologic information, notwithstanding its weak correlation with extant diagnostic schemes for mental disorders, for safer and expeditious treatment for mental disorders, discovering new applications for therapeutic entities, improved testing of candidate therapeutic entities, inferring the presence or absence of a desirable response to a treatment, and deducing the mode of action of one or more therapeutic entities. In particular, methods for effectively comparing neurophysiologic information relative to a reference set are disclosed along with database-based tools for deducing therapeutic entity actions on particular patients such that these tools are readily accessible to remote users.
Electroencephalography Based Systems And Methods For Selecting Therapies And Predicting Outcomes
US Patent:
2009015, Jun 18, 2009
Filed:
Nov 18, 2008
Appl. No.:
12/273304
Inventors:
Stephen C. Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - San Juan Capistrano CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - San Juan Capistrano CA, US
International Classification:
G06F 17/30
US Classification:
707 5, 707E17071
Abstract:
A method and system for utilizing neurophysiologic information obtained by techniques such as quantitative electroencephalography (QEEG), electrode recordings, MRI in appropriately matching patients with therapeutic entities is disclosed. The present invention enables utilization of neurophysiologic information, notwithstanding its weak correlation with extant diagnostic schemes for mental disorders, for safer and expeditious treatment for mental disorders, discovering new applications for therapeutic entities, improved testing of candidate therapeutic entities, inferring the presence or absence of a desirable response to a treatment, and deducing the mode of action of one or more therapeutic entities. In particular, methods for effectively comparing neurophysiologic information relative to a reference set are disclosed along with database-based tools for deducing therapeutic entity actions on particular patients such that these tools are readily accessible to remote users.
Method Of Recommending Neurophysiological Therapies
US Patent:
7962204, Jun 14, 2011
Filed:
Nov 18, 2008
Appl. No.:
12/273383
Inventors:
Stephen C. Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - San Juan Capistrano CA, US
W. Hamlin Emory - Malibu CA, US
Leonard J. Brandt - San Juan Capistrano CA, US
Assignee:
CNS Response, Inc. - Aliso Viejo CA
International Classification:
A61B 5/04
US Classification:
600544, 600545
Abstract:
A method and system for utilizing neurophysiologic information obtained by techniques such as quantitative electroencephalography (QEEG), electrode recordings, MRI in appropriately matching patients with therapeutic entities is disclosed. The present invention enables utilization of neurophysiologic information, notwithstanding its weak correlation with extant diagnostic schemes for mental disorders, for safer and expeditious treatment for mental disorders, discovering new applications for therapeutic entities, improved testing of candidate therapeutic entities, inferring the presence or absence of a desirable response to a treatment, and deducing the mode of action of one or more therapeutic entities. In particular, methods for effectively comparing neurophysiologic information relative to a reference set are disclosed along with database-based tools for deducing therapeutic entity actions on particular patients such that these tools are readily accessible to remote users.
Methods For Classifying And Treating Physiologic Brain Imbalances Using Quantitative Eeg
US Patent:
8562951, Oct 22, 2013
Filed:
May 25, 2010
Appl. No.:
12/786830
Inventors:
Stephen Suffin - Sherman Oaks CA, US
W. Hamlin Emory - Los Angeles CA, US
W. Hamlin Emory - Los Angeles CA, US
Assignee:
CNS Response - Aliso Viejo CA
International Classification:
A61K 49/00
US Classification:
424 92, 424 111, 424 165, 424 91
Abstract:
Neurophysiologic information such as quantitative electroencephalography (QEEG) is used in a method for classifying, diagnosing, and treating physiologic brain imbalances. Neurophysiologic information is also used to guide sample selection in clinical tests for psychopharmacologic drug candidates. Finally, neurophysiologic information is used for remotely assessing and treating patients with physiologic brain imbalances.
Method For Determining Drug Effects Using Quantitative Eeg
US Patent:
7754190, Jul 13, 2010
Filed:
Jun 23, 2003
Appl. No.:
10/602077
Inventors:
Stephen Suffin - Sherman Oaks CA, US
Assignee:
CNS Response, Inc. - Aliso Viejo CA
International Classification:
A61K 49/00
US Classification:
424 92, 424 111, 424 165, 424 91, 600544, 600545
Abstract:
Neurophysiologic information such as quantitative electroencephalography (QEEG) is used in a method for classifying, diagnosing, and treating physiologic brain imbalances. Neurophysiologic information is also used to guide sample selection in clinical tests for psychopharmacologic drug candidates. Finally, neurophysiologic information is used for remotely assessing and treating patients with physiologic brain imbalances.
Medical Practice licenses in California
ERIC CHRISTIAN LYDEN, Medical Practice, 4881 Topanga Canyon Blvd SUITE 210, Woodland Hills, CA 91364